Celera has become an independent publicly traded company that holds the businesses, assets and liabilities previously attributed to the Celera Group.
With the separation of Celera, Applera will no longer operate under its former tracking stock structure. Applied Biosystems stock will continue to be listed on the New York stock exchange under the symbol ‘ABI’.
On June 12, 2008, Applera and Invitrogen have announced that their boards of directors had approved a definitive merger agreement under which Invitrogen will acquire all of the outstanding shares of Applied Biosystems stock.
The merger is subject to customary closing conditions and is targeted to close in the fall of 2008. Following the close of the merger, the combined organization will be named Applied Biosystems.